Amit Sachdev - 17 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
17 Feb 2022
Transactions value $
-$813,087
Form type
4
Filing time
22 Feb 2022, 16:01:16 UTC
Previous filing
14 Feb 2022
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$813K -3.5K -5.92% $232.51 55.6K 17 Feb 2022 Direct
holding VRTX Common Stock 882 17 Feb 2022 401(k)
holding VRTX Common Stock 15.6K 17 Feb 2022 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.